StockData
Nuvation Bio Inc. logo

Nuvation Bio Inc. (NUVB) stock

NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30107% above fair value
$3.90+0.06 (+1.56%)

Close on Nov 17, 2026Market cap $1.37BP/E –Yield –

Nuvation Bio cash

Cash and short-term investments held at the end of each period.

Nuvation Bio's cash was $660.96M at Jun 30, 2026. For fiscal 2025 it was $529.21M, up 5.3% from the year before. The highest annual figure on record is $765.39M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$529.21M+5.3%
FY2024Dec 31, 2024$502.69M-17.8%
FY2023Dec 31, 2023$611.21M-7.5%
FY2022Dec 31, 2022$661.01M-13.6%
FY2021Dec 31, 2021$765.39M+254.8%
FY2020Dec 31, 2020$215.75M+6119.4%
FY2019Dec 31, 2019$3.47M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$660.96M+8.8%
Q1 FY2026Mar 31, 2026$533.73M+15.6%
Q4 FY2025Dec 31, 2025$529.21M+5.3%
Q3 FY2025Sep 30, 2025$549.05M-0.0%
Q2 FY2025Jun 30, 2025$607.72M+5.3%
Q1 FY2025Mar 31, 2025$461.68M-22.7%
Q4 FY2024Dec 31, 2024$502.69M-17.8%
Q3 FY2024Sep 30, 2024$549.14M-11.3%
Q2 FY2024Jun 30, 2024$577.17M-8.5%
Q1 FY2024Mar 31, 2024$596.98M-7.7%
Q4 FY2023Dec 31, 2023$611.21M-7.5%
Q3 FY2023Sep 30, 2023$619.34M-8.1%
Q2 FY2023Jun 30, 2023$630.90M-10.4%
Q1 FY2023Mar 31, 2023$646.61M-12.3%
Q4 FY2022Dec 31, 2022$661.01M-13.6%
Q3 FY2022Sep 30, 2022$673.95M-14.9%
Q2 FY2022Jun 30, 2022$703.80M-12.7%
Q1 FY2022Mar 31, 2022$737.70M-10.6%
Q4 FY2021Dec 31, 2021$765.39M+254.8%
Q3 FY2021Sep 30, 2021$791.78M+9414.3%
Q2 FY2021Jun 30, 2021$806.61M+8533.3%
Q1 FY2021Mar 31, 2021$824.71M+15289.3%
Q4 FY2020Dec 31, 2020$215.75M+6119.4%
Q3 FY2020Sep 30, 2020$8.32M–
Q2 FY2020Jun 30, 2020$9.34M–
Q1 FY2020Mar 31, 2020$5.36M–
Q4 FY2019Dec 31, 2019$3.47M–

More Nuvation Bio figures

See a number that looks wrong?